SoftFoot Pro, the new-generation bionic foot
SoftFoot Pro, the new-generation bionic foot
From the Italian Institute of Technology in Genoa, already our customer with the resistive sensory maps and always engaged in the development of humanoid robots, arrives at G7 Healthcare a prosthetic foot that reacts like a natural foot and allows it to walk and adapt autonomously to obstacles and different types of terrain: this, in a nutshell, is the idea that led researchers at the Italian Institute of Technology to develop hashtag SoftFoot Pro.
From the Italian Institute of Technology in Genoa, already our customer with the resistive sensory maps and always engaged in the development of humanoid robots, arrives at G7 Healthcare a prosthetic foot that reacts like a natural foot and allows it to walk and adapt autonomously to obstacles and different types of terrain: this, in a nutshell, is the idea that led researchers at the Italian Institute of Technology to develop hashtag SoftFoot Pro.
The mechanism of SoftFoot Pro consists of a titanium arch connected to five high-strength plastic chains, which simulate the bone structure of the human foot. Each chain is connected by a pair of elastic bands and crossed longitudinally by a high-performance mechanical cable. This architecture makes it possible to replicate the 'windlass' mechanism, which evenly discharges the force applied during gait, contributing to walking efficiency.
In addition, the freedom of movement of the distal elements that make up each chain allows for increased grip on sloping terrain, improving safety for the SoftFoot Pro wearer. Finally, thanks to the flexibility of the toes and the arching movements of the sole of the foot and back, everyday gestures such as walking up and down stairs or tying shoes are possible.
Latest
-
-
03. March 2026Meeting IULM University Students: Innovation, Responsibility, and the Future of the Pharmaceutical Industry
-
13. February 2026WHX 2026 Highlights UAE as a Global Hub for Healthcare and Pharmaceuticals: eXinvest and Finchemo Engage with Industry Leaders
-
23. January 2026Finchemo Launches New Website and Operational Phase, Driving Investments in Innovative Healthcare and Pharma Companies
-
26. December 2025Europe Remains the Leading Source of Pharmaceuticals for Global Export: eXinvest of Emirates Leverages Strategic Partnerships
-
24. December 2025eXinvest of Emirates and Finchemo Thank Partners for a Year of Growth and Look Ahead to 2026 Expansion in the GCC
-
04. March 2026Leaders’ Table at the 76th Sanremo Festival: Networking Excellence on Board
-
03. March 2026Meeting IULM University Students: Innovation, Responsibility, and the Future of the Pharmaceutical Industry
-
13. February 2026WHX 2026 Highlights UAE as a Global Hub for Healthcare and Pharmaceuticals: eXinvest and Finchemo Engage with Industry Leaders
-
23. January 2026Finchemo Launches New Website and Operational Phase, Driving Investments in Innovative Healthcare and Pharma Companies
-
26. December 2025Europe Remains the Leading Source of Pharmaceuticals for Global Export: eXinvest of Emirates Leverages Strategic Partnerships
-
24. December 2025eXinvest of Emirates and Finchemo Thank Partners for a Year of Growth and Look Ahead to 2026 Expansion in the GCC